IDEXX Free Cash Flow vs Ev To Free Cash Flow Analysis

IDXX Stock

USD 543.45 2.51 0.46%

IDEXX Laboratories financial indicator trend analysis is infinitely more than just investigating IDEXX Laboratories recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether IDEXX Laboratories is a good investment. Please check the relationship between IDEXX Laboratories Free Cash Flow and its Ev To Free Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

Free Cash Flow vs Ev To Free Cash Flow

Free Cash Flow vs Ev To Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of IDEXX Laboratories Free Cash Flow account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have strong relationship.

The correlation between IDEXX Laboratories' Free Cash Flow and Ev To Free Cash Flow is 0.64. Overlapping area represents the amount of variation of Free Cash Flow that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of IDEXX Laboratories, assuming nothing else is changed. The correlation between historical values of IDEXX Laboratories' Free Cash Flow and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Free Cash Flow of IDEXX Laboratories are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of Free Cash Flow i.e., IDEXX Laboratories' Free Cash Flow and Ev To Free Cash Flow go up and down completely randomly.

Correlation Coefficient

0.64

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Free Cash Flow

The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.

Most indicators from IDEXX Laboratories' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into IDEXX Laboratories current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.At this time, IDEXX Laboratories' Enterprise Value Over EBITDA is fairly stable compared to the past year. Enterprise Value Multiple is likely to rise to 44.60 in 2024, whereas Selling General Administrative is likely to drop slightly above 171.1 M in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	1.9B	2.0B	2.2B	2.3B
Total Revenue	3.2B	3.4B	3.7B	3.8B

Gross Profit Total Revenue

IDEXX Laboratories fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Non Current Liabilities Total	Intangible Assets	Short Long Term Debt Total	Short Term Debt	Property Plant And Equipment Gross	Common Stock Total Equity	Common Stock
Total Assets		0.97	0.75	0.73	0.98	0.33	0.91	0.95	0.63	0.98	0.84	0.48	0.99	-0.32	0.97	0.97	-0.92	0.82	0.96	0.77	0.72	0.63	0.11	0.9	0.6	0.54
Other Current Liab	0.97		0.7	0.65	0.99	0.39	0.86	0.97	0.52	0.98	0.88	0.36	0.98	-0.42	0.92	0.95	-0.89	0.85	0.89	0.86	0.7	0.65	0.04	0.88	0.58	0.54
Total Current Liabilities	0.75	0.7		0.19	0.75	0.77	0.52	0.77	0.27	0.69	0.46	0.48	0.72	-0.28	0.76	0.8	-0.65	0.92	0.78	0.73	0.57	0.93	0.73	0.49	0.67	0.67
Total Stockholder Equity	0.73	0.65	0.19		0.64	-0.39	0.89	0.59	0.75	0.72	0.73	0.33	0.71	0.05	0.74	0.65	-0.75	0.2	0.69	0.19	0.61	-0.06	-0.39	0.82	0.25	0.14
Property Plant And Equipment Net	0.98	0.99	0.75	0.64		0.42	0.86	0.96	0.52	0.99	0.85	0.36	0.99	-0.39	0.94	0.96	-0.9	0.86	0.9	0.85	0.69	0.68	0.1	0.86	0.62	0.58
Net Debt	0.33	0.39	0.77	-0.39	0.42		0.0	0.47	-0.29	0.32	0.15	0.1	0.35	-0.52	0.31	0.41	-0.22	0.79	0.31	0.72	0.2	0.91	0.74	0.07	0.47	0.51
Retained Earnings	0.91	0.86	0.52	0.89	0.86	0.0		0.84	0.67	0.92	0.85	0.3	0.9	-0.19	0.93	0.9	-0.97	0.55	0.83	0.5	0.76	0.31	-0.11	0.89	0.41	0.33
Accounts Payable	0.95	0.97	0.77	0.59	0.96	0.47	0.84		0.4	0.97	0.85	0.3	0.97	-0.43	0.93	0.95	-0.89	0.86	0.87	0.83	0.74	0.69	0.15	0.87	0.58	0.53
Cash	0.63	0.52	0.27	0.75	0.52	-0.29	0.67	0.4		0.52	0.39	0.76	0.55	0.18	0.56	0.52	-0.55	0.27	0.73	0.23	0.36	0.11	-0.14	0.61	0.4	0.32
Non Current Assets Total	0.98	0.98	0.69	0.72	0.99	0.32	0.92	0.97	0.52		0.9	0.31	0.99	-0.37	0.96	0.97	-0.94	0.79	0.89	0.78	0.74	0.59	0.03	0.9	0.55	0.5
Non Currrent Assets Other	0.84	0.88	0.46	0.73	0.85	0.15	0.85	0.85	0.39	0.9		0.09	0.88	-0.32	0.83	0.82	-0.83	0.59	0.7	0.62	0.68	0.35	-0.19	0.82	0.38	0.33
Cash And Short Term Investments	0.48	0.36	0.48	0.33	0.36	0.1	0.3	0.3	0.76	0.31	0.09		0.39	0.08	0.39	0.34	-0.23	0.41	0.7	0.31	0.12	0.42	0.3	0.38	0.43	0.39
Net Receivables	0.99	0.98	0.72	0.71	0.99	0.35	0.9	0.97	0.55	0.99	0.88	0.39		-0.38	0.96	0.96	-0.91	0.82	0.92	0.8	0.7	0.62	0.06	0.9	0.57	0.51
Common Stock Shares Outstanding	-0.32	-0.42	-0.28	0.05	-0.39	-0.52	-0.19	-0.43	0.18	-0.37	-0.32	0.08	-0.38		-0.27	-0.32	0.3	-0.5	-0.22	-0.63	0.11	-0.48	-0.02	-0.34	0.13	0.2
Inventory	0.97	0.92	0.76	0.74	0.94	0.31	0.93	0.93	0.56	0.96	0.83	0.39	0.96	-0.27		0.97	-0.93	0.77	0.92	0.68	0.78	0.59	0.17	0.87	0.57	0.5
Other Current Assets	0.97	0.95	0.8	0.65	0.96	0.41	0.9	0.95	0.52	0.97	0.82	0.34	0.96	-0.32	0.97		-0.96	0.83	0.9	0.76	0.8	0.67	0.21	0.83	0.6	0.55
Other Stockholder Equity	-0.92	-0.89	-0.65	-0.75	-0.9	-0.22	-0.97	-0.89	-0.55	-0.94	-0.83	-0.23	-0.91	0.3	-0.93	-0.96		-0.68	-0.82	-0.62	-0.79	-0.48	-0.06	-0.84	-0.49	-0.42
Total Liab	0.82	0.85	0.92	0.2	0.86	0.79	0.55	0.86	0.27	0.79	0.59	0.41	0.82	-0.5	0.77	0.83	-0.68		0.8	0.94	0.51	0.95	0.49	0.6	0.65	0.65
Total Current Assets	0.96	0.89	0.78	0.69	0.9	0.31	0.83	0.87	0.73	0.89	0.7	0.7	0.92	-0.22	0.92	0.9	-0.82	0.8		0.71	0.64	0.66	0.22	0.84	0.62	0.56
Non Current Liabilities Total	0.77	0.86	0.73	0.19	0.85	0.72	0.5	0.83	0.23	0.78	0.62	0.31	0.8	-0.63	0.68	0.76	-0.62	0.94	0.71		0.4	0.85	0.23	0.61	0.55	0.55
Intangible Assets	0.72	0.7	0.57	0.61	0.69	0.2	0.76	0.74	0.36	0.74	0.68	0.12	0.7	0.11	0.78	0.8	-0.79	0.51	0.64	0.4		0.35	0.15	0.64	0.65	0.63
Short Long Term Debt Total	0.63	0.65	0.93	-0.06	0.68	0.91	0.31	0.69	0.11	0.59	0.35	0.42	0.62	-0.48	0.59	0.67	-0.48	0.95	0.66	0.85	0.35		0.69	0.37	0.59	0.62
Short Term Debt	0.11	0.04	0.73	-0.39	0.1	0.74	-0.11	0.15	-0.14	0.03	-0.19	0.3	0.06	-0.02	0.17	0.21	-0.06	0.49	0.22	0.23	0.15	0.69		-0.18	0.43	0.47
Property Plant And Equipment Gross	0.9	0.88	0.49	0.82	0.86	0.07	0.89	0.87	0.61	0.9	0.82	0.38	0.9	-0.34	0.87	0.83	-0.84	0.6	0.84	0.61	0.64	0.37	-0.18		0.38	0.28
Common Stock Total Equity	0.6	0.58	0.67	0.25	0.62	0.47	0.41	0.58	0.4	0.55	0.38	0.43	0.57	0.13	0.57	0.6	-0.49	0.65	0.62	0.55	0.65	0.59	0.43	0.38		0.97
Common Stock	0.54	0.54	0.67	0.14	0.58	0.51	0.33	0.53	0.32	0.5	0.33	0.39	0.51	0.2	0.5	0.55	-0.42	0.65	0.56	0.55	0.63	0.62	0.47	0.28	0.97

Click cells to compare fundamentals

IDEXX Laboratories Account Relationship Matchups

IDEXX Laboratories fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	1.8B	2.3B	2.4B	2.7B	3.3B	3.4B
Other Current Liab	322.9M	415.6M	458.9M	433.7M	478.7M	502.6M
Total Current Liabilities	725.3M	582.8M	763.6M	1.2B	951.5M	999.1M
Total Stockholder Equity	177.5M	632.1M	690.0M	608.7M	1.5B	1.6B
Property Plant And Equipment Net	533.8M	555.2M	587.7M	649.5M	702.2M	737.3M
Net Debt	897.3M	524.6M	779.2M	1.2B	493.9M	255.9M
Retained Earnings	1.6B	2.2B	2.9B	3.6B	4.4B	4.7B
Accounts Payable	72.2M	74.6M	116.1M	110.2M	110.6M	116.2M
Cash	90.3M	383.9M	144.5M	112.5M	453.9M	476.6M
Non Current Assets Total	1.2B	1.2B	1.5B	1.6B	1.8B	1.9B
Non Currrent Assets Other	299.0M	337.2M	397.4M	425.6M	448.5M	470.9M
Cash And Short Term Investments	90.3M	383.9M	144.5M	112.5M	453.9M	476.6M
Net Receivables	269.3M	331.4M	368.3M	400.6M	457.4M	480.3M
Common Stock Shares Outstanding	87.5M	86.7M	86.6M	84.6M	84.0M	94.9M
Liabilities And Stockholders Equity	1.8B	2.3B	2.4B	2.7B	3.3B	3.4B
Inventory	195.0M	209.9M	269.0M	367.8M	380.3M	399.3M
Other Current Assets	125.0M	137.5M	173.8M	220.5M	203.6M	213.8M
Other Stockholder Equity	(1.4B)	(1.5B)	(2.2B)	(2.9B)	(2.9B)	(2.8B)
Total Liab	1.7B	1.7B	1.7B	2.1B	1.8B	1.9B
Total Current Assets	679.6M	1.1B	955.7M	1.1B	1.5B	1.6B
Non Current Liabilities Total	929.3M	1.1B	983.6M	902.2M	823.8M	865.0M
Intangible Assets	58.5M	52.5M	99.0M	97.7M	84.5M	74.5M
Short Long Term Debt Total	987.7M	908.5M	923.7M	1.3B	947.9M	995.3M
Short Term Debt	288.8M	50.0M	148.5M	654.0M	325.0M	208.6M
Property Plant And Equipment Gross	614.5M	646.3M	1.3B	649.5M	1.6B	1.7B
Accumulated Other Comprehensive Income	(46.2M)	(53.6M)	(53.5M)	(77.8M)	(71.2M)	(67.6M)
Common Stock Total Equity	10.6M	10.6M	10.7M	10.7M	12.3M	9.0M
Common Stock	10.6M	10.6M	10.7M	10.7M	10.8M	9.2M
Other Assets	240.2M	676.7M	893.9M	387.5M	445.6M	467.9M
Treasury Stock	(2.3B)	(2.6B)	(2.8B)	(3.6B)	(3.2B)	(3.1B)
Property Plant Equipment	533.8M	555.2M	587.7M	649.5M	746.9M	784.2M
Current Deferred Revenue	41.5M	42.6M	40.0M	37.9M	37.2M	25.0M
Good Will	239.7M	243.3M	359.3M	361.8M	366.0M	206.0M
Other Liab	162.8M	220.5M	208.4M	106.6M	122.6M	83.3M
Long Term Debt	698.9M	858.5M	775.2M	694.4M	622.9M	380.8M
Net Tangible Assets	(120.7M)	336.2M	690.0M	149.3M	134.3M	141.1M
Noncontrolling Interest In Consolidated Entity	264K	280K	352K	707K	813.1K	853.7K
Retained Earnings Total Equity	1.6B	2.2B	2.9B	3.6B	4.1B	4.3B
Long Term Debt Total	698.9M	858.5M	775.2M	694.4M	798.5M	502.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

MSFT	Microsoft
GOOG	Alphabet Inc Class C
C	Citigroup

When determining whether IDEXX Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of IDEXX Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Idexx Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Idexx Laboratories Stock:

How To Invest In IDEXX

Details

Is IDEXX Stock a good investment?

Details

What is IDEXX Laboratories' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in IDEXX Laboratories. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

For more information on how to buy IDEXX Stock please use our How to Invest in IDEXX Laboratories guide.

You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for IDEXX Stock analysis

When running IDEXX Laboratories' price analysis, check to measure IDEXX Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IDEXX Laboratories is operating at the current time. Most of IDEXX Laboratories' value examination focuses on studying past and present price action to predict the probability of IDEXX Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IDEXX Laboratories' price. Additionally, you may evaluate how the addition of IDEXX Laboratories to your portfolios can decrease your overall portfolio volatility.

	Stocks Directory Find actively traded stocks across global markets
	Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments
	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	FinTech Suite Use AI to screen and filter profitable investment opportunities
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings

Is IDEXX Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of IDEXX Laboratories. If investors know IDEXX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about IDEXX Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.102

Earnings Share

10.33

Revenue Per Share

44.828

Quarterly Revenue Growth

0.071

Return On Assets

0.2263

The market value of IDEXX Laboratories is measured differently than its book value, which is the value of IDEXX that is recorded on the company's balance sheet. Investors also form their own opinion of IDEXX Laboratories' value that differs from its market value or its book value, called intrinsic value, which is IDEXX Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IDEXX Laboratories' market value can be influenced by many factors that don't directly affect IDEXX Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between IDEXX Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if IDEXX Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IDEXX Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

IDEXX Free Cash Flow vs Ev To Free Cash Flow Analysis

Free Cash Flow vs Ev To Free Cash Flow

Free Cash Flow vs Ev To Free Cash Flow Correlation Analysis

Correlation Coefficient

Free Cash Flow

Ev To Free Cash Flow

IDEXX Laboratories fundamental ratios Correlations

IDEXX Laboratories Account Relationship Matchups

High Positive Relationship

High Negative Relationship

IDEXX Laboratories fundamental ratios Accounts

Also Currently Popular

Complementary Tools for IDEXX Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Receivables	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Other Current Liab
Non Current Assets Total	+ 0.99	Property Plant And Equipment Net
Net Receivables	+ 0.99	Property Plant And Equipment Net
Net Receivables	+ 0.99	Non Current Assets Total
Property Plant And Equipment Net	+ 0.98	Total Assets

Other Stockholder Equity	- 0.97	Retained Earnings
Other Stockholder Equity	- 0.96	Other Current Assets
Other Stockholder Equity	- 0.94	Non Current Assets Total
Other Stockholder Equity	- 0.93	Inventory
Other Stockholder Equity	- 0.92	Total Assets
Other Stockholder Equity	- 0.91	Net Receivables